[1]
“Investigating the Relationship between Using Natalizumab in Patients with Multiple Sclerosis on Developing Depression”, Eur. J. Behav. Sci., vol. 6, no. 2, pp. 1–9, Jun. 2023, doi: 10.33422/ejbs.v6i2.1003.